CMPS COMPASS Pathways

$CMPS we are at 4 month lows in a company that is going to be FDA approved in psychedelic medicine in maximum 3 months. Buy now or forever regret. These headlines will be insane. Many need these medicines. Everybody enjoy your day, smile through the ups and downs!

$CMPS a green Friday is nice to see. If it stays who knows. We are still a long long way from where this should/will be. $40-50 is not unrealistic. I do hope the fda approval goes smoothly. They could very easily throw a wrench into the psychedelic sector by making the REMS extremely difficult. I hope that is not the case. There is no reason psilocybin and lsd should not be available for people who struggle with depression, anxiety and trauma. Yes need to be careful with specific people and backgrounds but that does the same for certain antidepressants and plenty of other medicines in this realm. Side effects are actually quite minimal with psychedelics. 🍄🚀

$CMPS Don't discount the first mover/novelty hype cycle that propelled this to $59 in the beginning. It's all about to happen again with NDA submission and FDA approval.

$CMPS I have seen classified ads for jobs at Compass, interviews have been conducted for many ancillary positions in the anticipation of an FDA approval. The NDA has to be days away from being filed based on what I have read, too many people involved. This process to date has been well planned and will succeed!!!

$CMPS Interesting. If you recall, Kodiak Sciences jumped $60 a share late Sept from $30 in reporting its Phase 3 eye drug results. Just checked, it has held that gain. That may be us upon FDA approval.

$CMPS biotech is back! Waiting for the NDA to be finalized any day now. Then it’s CNPV 1-2 month timeline from filing until approval! Maybe still this year!

$CMPS has a lot of room to run when this decides to run. Could be to the 20s could be pushing the 100s after approval. First ever classic psychedelic to approved. I am hoping the fomo and chasing hits this really hard when it starts moving into clinics. Bear case is the 20s honestly and people wait until they see the actual revenue and earnings in a year or two. Bull case - the fomo hits, people chase and the entire mental health paradigm is shifted because of it 🍄

$CMPS been a wack month. Hopefully scraping all the non believers out before the inevitable pop and then people be chasin’ 🍄 although overall market is not look super promising for midterms and post midterms

$CMPS goes without saying but the more time that passes the closer we are to the inevitable FDA decision. Regardless of when NDA is submitted the market will see each day as a day closer to approval. Have a great night!

$CMPS FOMO should start with soon-coming PR about NDA submission finalized. At that point investors must realize, that CNPV means only 1-2 months from NDA filing until approval. But the masses of new investors will come, when there’s worlwide news of first-ever psychedelic being approved by FDA as a medicine.

$CMPS I am very excited to see Point 72 aka Steve Cohen has a substantial position in Compass, these type of investors very rarely loose.

$CMPS sadly these days/gains mean nothing until it gains and HOLDS. We just saw a 7%+ day jump less than 2 weeks ago and gave it back in 4-5 days later. Would love to see natural uptick based on momentum of news aka buzz to the high teens and then NDA submission jump and approval jump. If after NDA $CMPS is under $20/share, BO is the play.

$CMPS Something to keep in mind about DEA reclassification time after FDA approval: "The White House Executive Order 14401 ("Accelerating Medical Treatments for Serious Mental Illness") fundamentally changes the federal rescheduling timeline by allowing the DEA to review a drug before it receives final FDA approval. By instructing the Attorney General and the DEA to initiate and complete rescheduling reviews immediately upon the successful completion of Phase 3 clinical trials—rather than waiting for the FDA's final market approval—the executive order aims to collapse the two historically sequential timelines into a parallel process. Because the DEA is directed to complete its review while the drug is still under FDA review, the 90-day post-approval clock could essentially be reduced to zero days. The goal is to align the DEA’s final rescheduling order to publish simultaneously with, or immediately following, the FDA's approval decision."

$CMPS Price today doesnt matter. If it went to 15 again, I still wouldnt sell. Its too close for everything to start happening fast. 5 or 6 months still....but dont short yourselves!

$CMPS Spravato Q3 sales up 36% YOY (624 Million vs. 459 Million) from $JNJ earnings report. 9 months sales up 40% (1,676 Million vs. 1,193 Million). Growth is still there. YTD free cash flow ~15.1 Billion. They have the funds for a buyout 👀

$CMPS Become a case study the last few weeks why DCA is the way to go when you know at least a month or so is left before a major catalyst for any given stock, particularly battleground small cap. Been doing so almost daily and plan on being done by eow / before ER and the big NDA PR.

$CMPS For anyone who worries that something is wrong with CMPS every time is dips ... They all move up and down together. Nothing has changed (disregard ATAI which sold itself out for peanuts)

$CMPS bottoming out at $11 with NDA and FDA approval looming is insane! Can’t wait anylonger for blast off.

$CMPS I have been a bit critical of kabir comments recently, but I firmly believe those who are buying these days will be handsomely rewarded if patient long term investors. This is a buy and park and forget story that will be a 2 to 4 bagger. Your money, your call. My strategy is gradual accumulation at these prices. And I won’t mind if it goes lower from here.

$CMPS under promise, over deliver. He is watching his words and behavior closely. That isn't a bad thing to me. Remember when Christian was all sunshine and rainbows about the long road to commericalization right before the LLY rug pull of a deal? I would rather Kabir appear reserved rather than "gung ho". That would be a red flag for a reputable CEO imo. Not worried, let's ride